AQMS stock forecast draws from peer performance in the battery tech sector, showing correlated growth patterns that could lift share price by year-end. Based in Bannockburn, Illinois, Stericycle Inc. (NASDAQ:SRCL) is an American compliance company which focuses on the collection, disposal, and recycling of regulated medical waste and sharps, pharmaceuticals, and hazardous waste. It also provides services for recalled and expired goods. On November 4, RBC cut the price target on Stericycle Inc. (NASDAQ:SRCL) to $58 from $62, but maintained an Outperform rating on the stock. As per the analyst, the company is aiming to generate an impressive +13%-17% EBITDA expansion per year for the forecast period 2023-2027 and shows inclination and potential to indulge in accretive acquisitions, having completed more than 17 business sales since 2018. The analysts opines that Stericycle Inc. (NASDAQ:SRCL) intends to divert greater focus on value-accretive divestments and business sales in the near future, making it an attractive long-term buy. According to CCO Cory White in Stericycle's (NASDAQ:SRCL) Q3 2023 earnings call transcript : Pros: Enticingly, the market cap for Gevo only sits at less than $291 million. Therefore, getting a modest piece of the pie could lead to significant upside. Analysts see shares hitting $6.07 , implying growth potential of nearly 402%. Upcoming catalysts in AQMS stock forecast include regulatory approvals and potential government incentives, enhancing the growth story for investors.